LifeSource Vitamins
Rated 4.8 out of 5
5 Reviews

Silymarin - Milk Thistle Extract - 300mg - 100 Veg Capsules

Original Price: $26.99   Current Price: $26.99
  • Supports healthy liver function and wellness*
  • Supports natural detoxification processes*
  • Provides nutritional support for cellular health*
  • Supports metabolic health and balance*
  • Supports natural inflammatory response*
  • Supports cardiovascular wellness*
  • Standardized 300 mg milk thistle extract*
  • Third-Party Tested for Purity & Quality*
Purchase options
Recurring Subscription

You might also like

Product Details

Silymarin (Milk Thistle) — Vegetarian Capsules — Supports Healthy Liver Enzymes, Antioxidant Defense & Metabolic Balance*

LifeSource Vitamins Silymarin (Milk Thistle) provides a standardized extract from Silybum marianum to support healthy liver enzyme balance, cellular antioxidant defenses, and everyday wellness. Produced in FDA-registered, GMP-certified facilities and 3rd-party tested for identity, potency & purity.*

Research-Driven & Verified Product.
Explore the clinical research, ingredient science, and global evidence supporting this product below.
Research Promise: At LifeSource Vitamins, our commitment is rooted in research and results. Every benefit below is supported by human clinical studies indexed in the National Institutes of Health (NIH) via PubMed, with full texts available in the National Library of Medicine (NLM) PubMed Central (PMC) when available. In addition, we reference reviews from 39 leading health organizations and insights from 20 top global universities to ensure our guidance aligns with credible science.*
Clinically Studied Benefits

Liver enzymes in NAFLD — Silybin–phosphatidylcholine + vitamin E improved ALT and metabolic markers. NIH/PubMed — Loguercio, 2012

Insulin resistance & liver damage in NAFLD — Silybin–vitamin E–phospholipid complex showed improvements. NIH/PMC — Federico, 2006

NASH (high-dose silymarin) — Safety confirmed; exploratory fibrosis signals; mixed primary endpoints. NIH/PubMed — Navarro, 2019

NASH 48-week RCT — Primary NAS endpoint not met; well-tolerated; possible antifibrotic signal. NIH/PubMed — Kheong, 2017

Type 2 Diabetes — 4-month RCT improved glycemic profile vs placebo. NIH/PubMed — Huseini, 2006

T2D adjunct — Added to glibenclamide improved glycemic control in 120-day RCT. NIH/PubMed — Hussain, 2007

Diabetic nephropathy — Reduced albuminuria vs placebo on RAS blockade. NIH/PubMed — Fallahzadeh, 2012

Acute viral hepatitis — RCT assessed symptoms, labs, safety; generally well-tolerated. NIH/PMC — El-Kamary, 2009

Chronic HCV (high-dose) — No ALT benefit vs placebo; high-dose safety characterized. NIH/PubMed — Fried, 2012

Alcohol-related cirrhosis (oxidative markers) — Increased GSH, decreased lipid peroxidation vs placebo at 6 months. NIH/PubMed — Lucena, 2002

Additional / Promising Evidence

NAFLD meta-analysis — Pooled RCTs associate silymarin with ALT/AST reductions. NIH/PubMed — Zhong, 2017

NAFLD systematic review (2024) — Signals for enzyme and histology improvements; calls for larger RCTs. NIH/PubMed — Li, 2024

Chronic liver disease RCT (2024) — Reduced ALT/AST vs standard care; stronger effects in metabolic liver disease. NIH/PubMed — Amjad, 2024

Diabetes & lipids review — Summarizes glycemic and lipid findings; safety profile. NIH/PMC — Xiao, 2020

HCV community study (follow-up) — Symptom/well-being improvement; mixed virologic/biochemical outcomes. NIH/PubMed — Strickland, 2005

Pharmacokinetics in HCV — Multiple-dose escalation characterized exposure at higher doses. NIH/PubMed — Hawke, 2010

University-Led & Academic Studies

University of Naples (Italy) — NAFLD improvements with silybin–vitamin E–phospholipids. NIH/PMC — Federico, 2006

University of Granada (Spain) — Antiperoxidative effects in alcoholic cirrhosis RCT. NIH/PubMed — Lucena, 2002

University of Tehran & collaborators — T2D RCTs reporting glycemic benefits. NIH/PubMed — Huseini, 2006

We monitor research from leading institutions — Harvard, Johns Hopkins, Mayo Clinic, Cleveland Clinic, Cambridge, Oxford, Stanford, Yale, Tufts, University of Florida, Oregon State University – Linus Pauling Institute, Columbia, Cornell, Ohio State — to align with credible science.*
Key Ingredients
  • Silymarin (Milk Thistle) Extract — Concentrated flavonolignans that support antioxidant defenses and healthy liver enzyme balance.*
Brief Benefit Bullets
  • Supports healthy liver enzyme balance (ALT/AST) in adults*
  • Helps defend cells from oxidative stress*
  • Supports metabolic balance and everyday wellness*
  • Gentle, well-tolerated herbal support*
  • 3rd-party lab tested for identity, potency & purity
Suggested Use

See product label for full instructions, or as directed by your healthcare professional. Do not exceed recommended dose. If pregnant, nursing, taking medications, or have a medical condition, consult your physician.*

Product Specifications

• Form — Easy-to-swallow vegetarian capsules

• Serving Size — See Supplement Facts label

• Servings Per Container — See Supplement Facts label

• Free From — Non-GMO, gluten-free; no artificial colors, preservatives or synthetic chemicals*

• Quality — Third-party tested for identity, potency & purity

3rd-Party Testing: Every batch is independently verified for identity, potency, and purity.
Click here to see our 3rd-party testing.

LifeSource Vitamins — Proudly American — Since 1992

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Silymarin (Milk Thistle) — supports healthy liver enzymes, antioxidant defense & metabolic balance. 3rd-party tested quality. Clinically Studied Ingredients — NIH/PubMed!*

You May Also Like